Bryan Burt named chief of thoracic surgery at UCLA Health

Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, UCLA-led study finds

A study led by UCLA Health Jonsson Comprehensive Cancer Center investigators suggests that adding hormone therapy to post-operative radiotherapy may provide little survival benefit for most men with prostate cancer, especially for those with very low PSA levels before treatment.

March 06, 2026

Vol.52 No.09

Black History Month Podcast

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”

Malcolm V. Brock, director of Clinical and Translational Research in Thoracic Surgery at Johns Hopkins Kimmel Comprehensive Cancer Center, grew up in Bermuda. His father insisted that his children branch outside the small island—the country has a population of just over 60,000 people—and challenge themselves abroad.

February 20, 2026

Vol.52 No.07

By Malcolm V. Brock, Robert A. Winn and Preston Willett

Clinical Roundup

Advanced PET/CT imaging can improve long-term outcomes in recurrent prostate cancer, UCLA-led study finds

A five-year retrospective study led by investigators at the UCLA Health Jonsson Comprehensive Cancer Center shows that prostate-specific membrane antigen PET/CT scans can help doctors target treatment more precisely for men whose prostate cancer returns after surgery, improving long-term outcomes and potentially reducing unnecessary side effects.

February 13, 2026

Vol.52 No.06

Clinical Roundup

Rural cancer patients do just as well as urban patients when having surgery close to home, study finds

Adults living in rural communities often travel long distances when seeking treatment for cancer, but distant travel may not always be necessary to receive high-quality surgical care.

February 13, 2026

Vol.52 No.06

Clinical Roundup

Lab-grown organoids reveal how glioblastoma resists treatment

UCLA scientists have developed advanced miniature 3D tumor organoid models that make it possible to study glioblastoma tumors in a setting that closely mirrors the human brain, shedding light on how the aggressive cancer interacts with surrounding brain cells and the immune system to become more invasive and resistant to therapy.

January 30, 2026

Vol.52 No.04

Clinical Roundup

UCLA launches trial comparing two types of PSMA radiopharmaceuticals for recurrent prostate cancer

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have opened a clinical trial that will look at whether combining precision radiation with a targeted radioactive therapy drug can help patients with recurrent prostate cancer delay progression, while delaying or avoiding the side effects of long-term hormone therapy.

January 30, 2026

Vol.52 No.04

Bryan Burt named chief of thoracic surgery at UCLA Health

YOU MAY BE INTERESTED IN

Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, UCLA-led study finds

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”

Advanced PET/CT imaging can improve long-term outcomes in recurrent prostate cancer, UCLA-led study finds

Rural cancer patients do just as well as urban patients when having surgery close to home, study finds

Lab-grown organoids reveal how glioblastoma resists treatment

UCLA launches trial comparing two types of PSMA radiopharmaceuticals for recurrent prostate cancer

Renew today!

Subscriber content

Never miss an issue!

Login

Bryan Burt named chief of thoracic surgery at UCLA Health

YOU MAY BE INTERESTED IN

Hormone therapy may not benefit most men receiving radiotherapy after prostate surgery, UCLA-led study finds

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology“When it gets down to brass tacks, relationships between each other, we’re all one.”

Advanced PET/CT imaging can improve long-term outcomes in recurrent prostate cancer, UCLA-led study finds

Rural cancer patients do just as well as urban patients when having surgery close to home, study finds

Lab-grown organoids reveal how glioblastoma resists treatment

UCLA launches trial comparing two types of PSMA radiopharmaceuticals for recurrent prostate cancer

Never miss an issue!

Login

Malcolm V. Brock on his journey from Bermuda to Japan to the U.S. to England–and from Japanese studies to thoracic oncology
“When it gets down to brass tacks, relationships between each other, we’re all one.”